Artificial intelligence (AI) is expected to bring transformative changes to healthcare over the next decade, with six major diseases identified as likely candidates for such advancements.

Experts suggest that improvements in AI will enhance precision in diagnosis, enable personalized treatments, and facilitate effective prevention strategies, ultimately reducing mortality rates and lessening the burden on healthcare systems.

The diseases anticipated to see significant advancements include cardiovascular diseases, various cancers (notably breast, lung, skin, prostate, and colon), type 2 diabetes, neurodegenerative diseases such as Alzheimer’s and Parkinson’s, infectious diseases, and genetic disorders.

These conditions are often associated with high rates of mortality or long-term disabilities, underscoring the importance of early prediction and intervention in combating them.

Dr. Omar Al Hamadi, Vice President of the Emirates Society of Internal Medicine and a consultant in internal medicine and lifestyle medicine, emphasized that the rapid developments in artificial intelligence represent a crucial turning point in healthcare.

He noted that coming years are likely to witness significant enhancements in the ability to predict chronic and serious diseases, making early detection and intervention a critical component of healthcare.

AI technologies promise vast improvements in treatment outcomes along with anticipated reductions in chronic disease and cancer-related mortality rates.

Early interventions bolstered by AI could lead to a decline in the incidence of these diseases, potentially rendering some treatable conditions obsolete in the future through enhanced diagnostic accuracy and targeted therapies.

In oncology, AI is increasingly utilized to analyze imaging data, improving the detection accuracy of tumors in their early stages.

For instance, advancements include a model that can identify pancreatic cancer an average of 438 days before a clinical diagnosis is made, even when symptoms are not present.

Other research has demonstrated an AI model capable of detecting endometrial cancer with an accuracy of 99.26%.

For cardiovascular health, AI techniques contribute to the analysis of electrocardiogram data, facilitating the early identification of potential heart issues.

Additionally, non-invasive sensors integrated with AI are employed to monitor patients’ physiological and environmental data, thereby supporting early detection and predicting the progression of chronic conditions.

In diabetes management, AI analyzes patient data to forecast risks of elevated or decreased blood sugar levels, allowing for proactive medical interventions.

Dr. Hisham Tayel, a cardiologist, asserted that AI has become an integral aspect of modern medicine, equipped with significant potential to enhance healthcare quality, hasten diagnosis, and help prevent diseases before they become critical.

AI technologies transform traditional healthcare models by assessing imaging results or laboratory data to provide preliminary diagnostic insights, alongside creating comprehensive health profiles through the integration of various health data, including electronic medical records, genetic factors, and familial histories.

This integration enables AI systems to analyze genetic predispositions and family medical histories to evaluate an individual’s future risks of chronic diseases or hereditary conditions, such as diabetes, cardiovascular diseases, or cancers, which empowers healthcare professionals to initiate early preventive measures.

Six main categories of diseases where AI is expected to significantly influence diagnosis, treatment, and prevention within the upcoming decade have been established.

These categories include cardiovascular diseases, where risks are predicted based on vital data and lifestyle factors, and cancers, including breast, lung, skin, prostate, and colon, where AI estimates risk based on genetics, behaviors, and environmental factors.

In addition, type 2 diabetes management is enhanced through monitoring devices that can alert patients of potential hypoglycemic or hyperglycemic incidents before they occur, along with tailored dietary and exercise programs based on biometric data analysis.

Neurological disorders benefit from AI through speech and movement pattern analysis for early indicators, while infectious diseases, such as influenza or COVID-19, can be predicted through communal health data and real-time outbreak modeling.

Genetic disorders are assessed by analyzing family history and genetic data to estimate risk levels for future conditions.

The role of AI transcends mere technological application as it becomes a vital partner in clinical efforts, fundamentally reshaping processes like diagnostic speed, family history analysis, early detection, and chronic disease management through sophisticated predictive capabilities.

Dr. Hanan Al Huna highlights AI as one of the foremost emerging tools in contemporary medicine, asserting its potential to bring significant change in early disease detection and chronic disease prevention through vast data analysis capabilities.

Dr. Yusuf Al Hosani, a consultant in public health and preventive medicine, noted that employing AI for early warning systems in epidemic monitoring could revolutionize health responses.

By utilizing extensive datasets with minimal human input, AI can drastically reduce the time taken to identify epidemic signals compared to traditional surveillance methods.

According to draft documents prepared for a global health summit, gaps in pandemic preparedness and response systems highlight the necessity for substantial investment into effective, resilient frameworks, with estimates suggesting a need for $31.1 billion to ensure comprehensive epidemic readiness.

Of that, an annual investment of $10.4 billion would be required for enhanced monitoring and early warning systems.

AI-driven systems empower decision-makers and emergency response institutions by providing timely and accurate data, analytical support, and specialized knowledge, significantly enhancing early detection of health risks.